Richard Robson Selected Research

Richard Robson Research Topics

4	Human Influenza (Influenza) 11/2015 - 09/2006
3	Chronic Renal Insufficiency 10/2020 - 11/2006
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2015 - 09/2006
2	Infections 10/2020 - 08/2008
1	Pain (Aches) 09/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Vascular Calcification 05/2018
1	Inflammation (Inflammations) 05/2018
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Activated Protein C Resistance (APC Resistance) 01/2017
1	Anuria 04/2015
1	Schizophrenia (Dementia Praecox) 08/2013
1	Hypertension (High Blood Pressure) 06/2012
1	IGA Glomerulonephritis (IGA Nephropathy) 06/2012
1	Metabolic Bone Diseases (Osteopenia) 08/2011
1	Osteoporosis 08/2011
1	Type 2 Diabetes Mellitus (MODY) 12/2009
1	Renal Insufficiency (Renal Failure) 05/2009
1	Hepatic Insufficiency 05/2009
1	Chronic Hepatitis C 08/2008
1	Anemia 11/2006
1	Body Weight (Weight, Body) 05/2005
1	Acute Coronary Syndrome 06/2002

5	Oseltamivir (Tamiflu)FDA Link 11/2015 - 05/2005
3	oseltamivir carboxylateIBA 11/2015 - 09/2006
2	Ribavirin (Virazole)FDA LinkGeneric 10/2020 - 08/2008
2	CreatinineIBA 10/2020 - 05/2009
1	dexamethasone 21-phosphate FDA LinkGeneric 09/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022
1	SofosbuvirIBA 10/2020
1	ledipasvirIBA 10/2020
1	ProteomeIBA 05/2018
1	apabetaloneIBA 05/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	oritavancinIBA 01/2017
1	Factor Xa (Coagulation Factor Xa)IBA 01/2017
1	Phosphates (Orthophosphate)IBA 06/2015
1	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 08/2013
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 08/2013
1	Immunoglobulin A (IgA)IBA 06/2012
1	Cholecalciferol (Vitamin D3)FDA Link 08/2011
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2011
1	25-hydroxyvitamin DIBA 08/2011
1	hydroxide ionIBA 08/2011
1	CalciumIBA 08/2011
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2009
1	Liraglutide FDA Link 12/2009
1	Raltegravir Potassium FDA Link 05/2009
1	balapiravirIBA 08/2008
1	Antiviral Agents (Antivirals)IBA 08/2008
1	NucleosidesIBA 08/2008
1	peginterferon alfa-2a (Pegasys)FDA Link 08/2008
1	continuous erythropoietin receptor activator FDA Link 11/2006
1	bivalirudin (Angiomax)FDA Link 06/2002

2	Peritoneal Dialysis 04/2015 - 11/2006
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 04/2015 - 09/2006
1	Renal Dialysis (Hemodialysis) 11/2015
1	Transplantation 06/2012
1	Drug Tapering 09/2006
1	Percutaneous Coronary Intervention 06/2002